Clinical Trials Browser

Active not recruiting × Disease × pembrolizumab × Clear all

NCT03728972 2025-10-23

Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal Type

Phase 2 Active not recruiting

19 enrolled 9 charts

Disease